Epothilone D
- Generic Name
- Epothilone D
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H41NO5S
- CAS Number
- 189453-10-9
- Unique Ingredient Identifier
- T0358E0YUF
- Indication
Investigated for use/treatment in colorectal cancer, lung cancer, breast cancer, solid tumors, and prostate cancer.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
- First Posted Date
- 2006-06-16
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 27
- Registration Number
- NCT00337649
Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy
Phase 2
Completed
- Conditions
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00081107
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2004-02-11
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00077259
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath